Combined Genome Sequencing and RNA Analysis Reveals and Characterizes a Deep Intronic Variant in IGHMBP2 in a Patient With Spinal Muscular Atrophy With Respiratory Distress Type 1
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Pediatric Neurology
- Vol. 114, 16-20
Abstract
No abstract availableKeywords
Funding Information
- National Human Genome Research Institute (U01 HG007942)
This publication has 16 references indexed in Scilit:
- Overturning the Paradigm of Spinal Muscular Atrophy as Just a Motor Neuron DiseasePediatric Neurology, 2020
- Reanalysis of Clinical Exome Sequencing DataNew England Journal of Medicine, 2019
- Whole genome sequencing reveals novel IGHMBP2 variant leading to unique cryptic splice‐site and Charcot‐Marie‐Tooth phenotype with early onset symptomsMolecular Genetics & Genomic Medicine, 2019
- Spinal muscular atrophy with respiratory distress type 1: A multicenter retrospective studyNeuromuscular Disorders, 2019
- IGHMBP2 mutation associated with organ-specific autonomic dysfunctionNeuromuscular Disorders, 2018
- Distal Spinal Muscular Atrophy: An Overlooked Etiology of Weaning Failure in Children with Respiratory InsufficiencyJournal of Pediatric Intensive Care, 2018
- Truncating and Missense Mutations in IGHMBP2 Cause Charcot-Marie Tooth Disease Type 2The American Journal of Human Genetics, 2014
- The wide spectrum of clinical phenotypes of spinal muscular atrophy with respiratory distress type 1: A systematic reviewJournal of the Neurological Sciences, 2014
- The Natural Course of Infantile Spinal Muscular Atrophy With Respiratory Distress Type 1 (SMARD1)Pediatrics, 2012
- Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1)Annals of Neurology, 2003